Correction to: Feasibility, Safety, and Efficacy of an Alternative Schedule of Sunitinib for the Tre...
Correction to: Feasibility, Safety, and Efficacy of an Alternative Schedule of Sunitinib for the Treatment of Patients with Metastatic Renal Cell Carcinoma: A Retrospective Study
About this item
Full title
Author / Creator
Publisher
Cham: Springer International Publishing
Journal title
Language
English
Formats
Publication information
Publisher
Cham: Springer International Publishing
Subjects
More information
Scope and Contents
Contents
In the Original Publication of the article, In Introduction part, 7th line, the value “5-100nM” has been published incorrectly. The correct value should read as “Plasma concentration of 50-100ng/ml”. In the Original Publication of the article, page 591, Table 2 has been published incorrectly. The corrected table is shown in the following page
Alternative Titles
Full title
Correction to: Feasibility, Safety, and Efficacy of an Alternative Schedule of Sunitinib for the Treatment of Patients with Metastatic Renal Cell Carcinoma: A Retrospective Study
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5995793
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5995793
Other Identifiers
ISSN
1174-5886
E-ISSN
1179-6901
DOI
10.1007/s40268-018-0234-z
